These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The immunologic effects of IVIG in Kawasaki disease. Leung DY. Int Rev Immunol; 1989; 5(2):197-202. PubMed ID: 8691053 [Abstract] [Full Text] [Related]
3. The potential role of cytokine-mediated vascular endothelial activation in the pathogenesis of Kawasaki disease. Leung DY. Acta Paediatr Jpn; 1991 Dec; 33(6):739-44. PubMed ID: 1801553 [Abstract] [Full Text] [Related]
6. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408 [Abstract] [Full Text] [Related]
16. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Pediatrics; 2004 Dec 22; 114(6):e689-93. PubMed ID: 15545617 [Abstract] [Full Text] [Related]